Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
VeinWay Ltd. logo — Changing the paradigm on treating chronic venous disease.

VeinWay Ltd.

Changing the paradigm on treating chronic venous disease.

Founded 2020 Israel Israel 9 employees Series A Health Care, Medical Devices

General Information

Company Name VeinWay Ltd.
Founded Year 2020
Location Israel Israel
Employees 9
Industries Health Care, Medical Devices
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with VeinWay Ltd.. To contact VeinWay Ltd., visit veinway.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does VeinWay Ltd. compare?

A PDF of VeinWay Ltd. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting VeinWay Ltd. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About VeinWay Ltd.

VeinWay Ltd. is a medical device company founded in 2020 by Jordan Pollack within the MEDX Xelerator incubator. The company's slogan "Changing the paradigm on treating chronic venous disease" reflects its mission to address unmet needs in the treatment of Chronic Venous Occlusions (CVOs). VeinWay's Traversa is the first dedicated device designed for venous recanalization, aiming to improve outcomes and enable physicians to reliably, safely, and easily complete endovascular procedures for the effective treatment of CVOs. The innovation has a significantly different approach compared to existing solutions on the market or currently in development, positioning it as a disruptive technology in the Health Care and Medical Devices industries. The company conducted discussions with established physicians from Europe, Israel, and the US, revealing the high unmet need for crossing CVOs in interventional radiology. With failure rates estimated between 10%-17%, and only around 10-13% of patients who need a venous stent actually receive one, VeinWay's Traversa aims to democratize physician access to the treatment of CVOs. The technology provides an unparalleled level of control that will enable interventional radiologists and vascular surgeons to cross occlusions every time, addressing the challenges posed by cumbersome recanalization of chronically occluded veins. The last Series A investment at 08 September 2023 reflects the interest and confidence of investors in VeinWay's innovative solution for the treatment of CVOs. As the company continues to progress, its ability to disrupt the market and improve patient outcomes could make it an attractive prospect for further investment. Based in Israel, VeinWay Ltd. stands at the forefront of addressing critical unmet needs in the field of interventional radiology and vascular surgery with its groundbreaking Traversa technology.

Business keywords: Medical Device Manufacturing, Interventional Radiology, Vascular Catheters, Venous Vasculature, Chronic Venous Disease, Vascular Surgery, Endovascular Procedures, Medical Technology, Innovation, Recanalization, Physician Access, Thrombotic Syndrome, Innovative Medical Devices, Data-driven Medical Solutions

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A Undisclosed -
08 Sep 2023
Non Equity Assistance Undisclosed 1
MedTech Innovator
MedTech Innovator
06 Jun 2023
Pre Seed Round Undisclosed 1
MEDX Xelerator
30 Dec 2021

VeinWay Ltd. Alternatives & Competitors

View All Alternatives
VeinWay Ltd. vs
Blueneem Medical Devices Pvt Ltd
Blueneem Medical Devices Pvt Ltd India

Blueneem is a Leader in Design, Development and End-to-end Manufacturing of Minimally-invasive Medic...

81 employees
Health Care, Manufacturing
VeinWay Ltd. vs
Relisys
Relisys

Pioneering advanced cardiovascular medical devices for life-saving heart treatments.

Private Equity
201-500 employees
Health Care, Manufacturing
VeinWay Ltd. vs
Saranas
Saranas United States

Give Bleeding the Bird

Series B
10 employees
Health Care, Medical Devices
Also compare with: VeinWay Ltd. vs Vivasure Medical Ltd. Vivasure Medical Ltd. VeinWay Ltd. vs Angiodroid Angiodroid View all alternatives

FAQ About VeinWay Ltd.

Changing the paradigm on treating chronic venous disease.
VeinWay Ltd. was founded in 2020.
VeinWay Ltd. is headquartered in Israel.
VeinWay Ltd. operates in Health Care and Medical Devices. Its work centres on Medical Device Manufacturing, Interventional Radiology, Vascular Catheters and Venous Vasculature.
VeinWay Ltd. has approximately 9 employees.
VeinWay Ltd. has completed 3 funding rounds. The latest funding stage is Series A.
Top alternatives and competitors to VeinWay Ltd. include Blueneem Medical Devices Pvt Ltd, Relisys, Saranas, EKOS Corporation, Artio Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
VeinWay Ltd. and Blueneem Medical Devices Pvt Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for VeinWay Ltd., https://bouncewatch.com/company/veinway, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout